Imparting mineral affinity to proteins with thiol-labile disulfide linkages

Journal of Biomedical Materials Research - Part A

Volumn 74, Issue 4, 2005, Pages 618-628

  Bansal, Geeti ^a   Wright, Jennifer E I ^a   Zhang, Sufeng ^a   Zernicke, Ronald F ^b   Uludag, Hasan ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Bisphosphonates; Disulfide linked conjugates; Mineral affinity; Proteins

Indexed keywords

AMINO ACIDS; BINDING ENERGY; BIOLOGICAL MATERIALS; BIOMATERIALS; MINERALS; PHYSIOLOGICAL MODELS; SOLUTIONS;

BISPHOSPHONATES; DISULFIDE LINKED BP; DISULFIDE-LINKED CONJUGATES; MINERAL AFFINITY;

PROTEINS;

3 (2 PYRIDYLDITHIO)PROPIONIC ACID N HYDROXYSUCCINIMIDE ESTER; BIOMATERIAL; BISPHOSPHONIC ACID DERIVATIVE; BOVINE SERUM ALBUMIN; CYSTEINE; DISULFIDE; HYDROXYAPATITE; MINERAL; PROPIONIC ACID DERIVATIVE; THIOL; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CONJUGATION; DISULFIDE BOND; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN SECRETION;

ANIMALS; CATTLE; COATED MATERIALS, BIOCOMPATIBLE; CYSTEINE; DIPHOSPHONATES; DISULFIDES; SERUM ALBUMIN, BOVINE; SUCCINIMIDES; SULFHYDRYL COMPOUNDS;

EID: 24044539193     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.a.30334     Document Type: Article

References (29)

1. Gittens SA, Uludag H. Growth factor delivery for bone tissue engineering, J Drug Target 2001;9:407-429.
2. Uludag H, D'Augusta D, Golden J, Li J, Timony G, Riedel R, Wozney JM. Implantation of recombinant human bone morphogenetic proteins with biomaterial carriers: a correlation between protein pharmacokinetics and osteoinduction in the rat ectopic model. J Biomed Mater Res 2000;50:227-238.
3. Gorbunoff MJ. The interaction of proteins with hydroxyapatite. I. Role of protein charge and structure. Anal Biochem 1984;136: 425-432.
4. Gittens SA, Bansal G, Zernicke RF, Uludag H. Designing protein-seeking proteins. Adv Drug Del Rev 2005. Forthcoming.
5. Uludag H, Kousinioris N, Gao T, Kantoci D. Bisphosphonate conjugation to proteins as a means to impart bone affinity. Biotech Prog 2000;16:258-267.
6. Uludag H, Yang J. Targeting systemically administered proteins to bone by bisphosphonate conjugation. Biotech Prog 2002;18:604-611.
7. Bansal G, Gittens SA, Uludag H. A di(bisphosphonic acid) for protein coupling and targeting to bone. J Pharm Sci 2004;93: 2788-2799.
8. Gittens SA, Matyas JR, Zernicke RF, Uludag H. Imparting bone affinity to glycoproteins through the conjugation of bisphosphonates. Pharm Res 2003;20:978-987.
9. Gittens SA, Kitov PI, Matyas JR, Loebenberg R, Uludag H. Impact of tether length on the bone mineral affinity of protein-bisphosphonate conjugates. Pharm Res 2004;21:608-616.
10. Kratz F, Beyer U, Schutte MT. Drug-polymer conjugates containing acid-cleavable bonds. Crit Rev Ther Drug Carrier Sys 1999;16:245-288.
11. Saito G, Swanson JA, Lee KD. Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities. Adv Drug Del Rev 2003,55:199-215.
12. Alferiev IS, Vyavahare NR, Song CV, Levy RJ. Elastomeric polyurethanes modified with geminal bisphosphonate groups. J Polym Sci Part A Polym Chem 2001;39:105-116.
13. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
14. Ames BN. Assay of inorganic phosphate, total phosphate, and phosphatases. In: Neufield EF, Ginsburg V, editors. Methods in enzymology, volume VIII, complex carbohydrates. New York: Academic Press; 1966. p 115-117.
15. Ezra A, Hoffman A, Breuer E, Alferiev IS, Monkkonen J, El Hanany-Rozen N, Weiss G, Stepensky D, Gati I, Cohen H, Tomalehto S, Amidon GL, Golomb G. A peptide prodrug approach for improving bisphosphonate oral absorption. J Med Chem 2000;43:3641-3652.
16. Degenhardt CR, Burdsall DC. Synthesis of ethenylidenebis(phosphonic acid) and its tertaalkyl esters. J Org Chem 1986; 51:3488-3490.
17. Masson S, Monique S, Marchand P. First synthesis of a (mercaptomethylene) diphosphonate via a phosphorothiolate → mercaptophosphonate rearrangement. Tetrahed 1998;54:1523-1528.
18. Almstead NG, Dansereau SM, Francis MD, Snider CM, Ebetino FH. The design and synthesis of sulfur containing bisphosphonic acids for the treatment of arthritis. Phosph Sulp Sil 1999;146:325-328.
19. Uludag H, Gao TJ, Wohl G, Zernicke RF, Kantoci D. Bone affinity of a bisphosphonate conjugated protein in vivo. Biotech Prog 2000;16:1115-1118.
20. Pastore A, Massoud R, Motti C, Russo AL, Fucci G, Cortese C, Federici G. Fully automated assay for total homocysteine, cysteine, cysteinylglycine, glutathione, cysteamine, and 2-mercaptoproionylglycine in plasma and urine. Clin Chem 1998;44: 825-832.
21. Hernanz A, Fernandez-Vivancos E, Montiel C, Vazquez JJ, Arnalich F. Changes in intracellular homocysteine and glutathione content associated with aging. Life Sci 2000;67:1317-1324.
22. Freter R, Pohl ER, Wilson JW, Hupe DJ. Role of the central thiol in determining rates of the thiol-disulfide interchange reaction. J Org Chem 1979;44:1771-1774.
23. Whitesides GM, Lilburn JE, Szajewski RP. Rates of thiol-disulfide reactions between mono- and dithiols and ellmans re-agent. J Org Chem 1977;42:332-338.
24. Stark AA, Arad A, Siskindovich S, Pagano DA, Zeiger E. Effect of pH on mutagenesis by thiols in Salmonella typhimurium TA102. Mutagen Res 1989;224:89-94.
25. Bai J, Acan B, Ghahary A, Ritchie B, Somayaji V, Uludag H. Poly(ethyleneimine)/arginine-aspartic acid conjugates prepared by N-succinimidyl 3-(2-pyridyldithio)propionate: an investigation of peptide coupling and conjugate stability. J Polym Sci Part A Polym Chem 2004;42:6143-6156.
26. Woo BH, Lee JT, Park MO, Lee KR, Han JW, Park ES, Yoo SD, Lee KC. Stability and cytotoxicity of Fab-ricin A immunotoxins prepared with water soluble long chain heterobifunctional crosslinking agents. Arch Pharmacal Res 1999;22:459-463.
27. Carroll SF, Bernhard SL, Goff DA, Bauer RJ, Leach W, Kung AH. Enhanced stability in vitro and in vivo of immunoconjugates prepared with 5-methyl-2-iminothiolane. Bioconj Chem 1994;5:248-256.
28. Neff JA, Tresco PA, Caldwell KD. Surface modification for controlled studies of cell-ligand interactions. Biomaterials 1999; 20:2377-2393.
29. Abdelghani-Jacquin C, Abdelghani A, Chmel G, Kantlehner M, Sackmann E. Decorated surfaces by biofunctionalized gold beads: application to cell adhesion studies. Eur Biophys J 2002;31:102-110.